| Apixaban versus warfarin in patients with atrial fibrillation CB Granger, JH Alexander, JJV McMurray, RD Lopes, EM Hylek, ... New England Journal of Medicine 365 (11), 981-992, 2011 | 10872 | 2011 |
| Rivaroxaban in patients with a recent acute coronary syndrome JL Mega, E Braunwald, SD Wiviott, JP Bassand, DL Bhatt, C Bode, ... New England Journal of Medicine 366 (1), 9-19, 2012 | 2441 | 2012 |
| International prevalence, recognition, and treatment of cardiovascular risk factors in outpatients with atherothrombosis DL Bhatt, PG Steg, EM Ohman, AT Hirsch, Y Ikeda, JL Mas, S Goto, ... Jama 295 (2), 180-189, 2006 | 2274 | 2006 |
| Long-term use of ticagrelor in patients with prior myocardial infarction MP Bonaca, DL Bhatt, M Cohen, PG Steg, RF Storey, EC Jensen, ... New England Journal of Medicine 372 (19), 1791-1800, 2015 | 2142 | 2015 |
| One-year cardiovascular event rates in outpatients with atherothrombosis PG Steg, DL Bhatt, PWF Wilson, R D’Agostino, EM Ohman, J Röther, ... Jama 297 (11), 1197-1206, 2007 | 1875 | 2007 |
| Comparative determinants of 4-year cardiovascular event rates in stable outpatients at risk of or with atherothrombosis DL Bhatt, KA Eagle, EM Ohman, AT Hirsch, S Goto, EM Mahoney, ... Jama 304 (12), 1350-1357, 2010 | 967 | 2010 |
| Empagliflozin in patients with chronic kidney disease EMPA-Kidney Collaborative Group New England Journal of Medicine 388 (2), 117-127, 2023 | 812 | 2023 |
| Rivaroxaban vs. warfarin in Japanese patients with atrial fibrillation–the J-ROCKET AF study– M Hori, M Matsumoto, N Tanahashi, S Momomura, S Uchiyama, S Goto, ... Circulation Journal 76 (9), 2104-2111, 2012 | 688 | 2012 |
| Efficacy and safety of statin therapy in older people: a meta-analysis of individual participant data from 28 randomised controlled trials J Armitage, C Baigent, E Barnes, DJ Betteridge, L Blackwell, M Blazing, ... The Lancet 393 (10170), 407-415, 2019 | 669 | 2019 |
| Effect of dapagliflozin on heart failure and mortality in type 2 diabetes mellitus ET Kato, MG Silverman, O Mosenzon, TA Zelniker, A Cahn, RHM Furtado, ... Circulation 139 (22), 2528-2536, 2019 | 613 | 2019 |
| Impact of diabetes mellitus on hospitalization for heart failure, cardiovascular events, and death: outcomes at 4 years from the Reduction of Atherothrombosis for Continued … MA Cavender, PG Steg, SC Smith Jr, K Eagle, EM Ohman, S Goto, ... Circulation 132 (10), 923-931, 2015 | 607 | 2015 |
| β-Blocker use and clinical outcomes in stable outpatients with and without coronary artery disease S Bangalore, G Steg, P Deedwania, K Crowley, KA Eagle, S Goto, ... Jama 308 (13), 1340-1349, 2012 | 602 | 2012 |
| Risk profiles and antithrombotic treatment of patients newly diagnosed with atrial fibrillation at risk of stroke: perspectives from the international, observational … AK Kakkar, I Mueller, JP Bassand, DA Fitzmaurice, SZ Goldhaber, S Goto, ... PloS one 8 (5), e63479, 2013 | 572 | 2013 |
| Metformin use and mortality among patients with diabetes and atherothrombosis R Roussel, F Travert, B Pasquet, PWF Wilson, SC Smith, S Goto, ... Archives of internal medicine 170 (21), 1892-1899, 2010 | 454 | 2010 |
| Distinct mechanisms of platelet aggregation as a consequence of different shearing flow conditions. S Goto, Y Ikeda, E Saldívar, ZM Ruggeri The Journal of clinical investigation 101 (2), 479-486, 1998 | 421 | 1998 |
| Three-year follow-up and event rates in the international REduction of Atherothrombosis for Continued Health Registry MJ Alberts, DL Bhatt, JL Mas, EM Ohman, AT Hirsch, J Röther, G Salette, ... European heart journal 30 (19), 2318-2326, 2009 | 418 | 2009 |
| Apixaban compared with warfarin in patients with atrial fibrillation and previous stroke or transient ischaemic attack: a subgroup analysis of the ARISTOTLE trial JD Easton, RD Lopes, MC Bahit, DM Wojdyla, CB Granger, L Wallentin, ... The Lancet Neurology 11 (6), 503-511, 2012 | 369 | 2012 |
| The REduction of Atherothrombosis for Continued Health (REACH) Registry: an international, prospective, observational investigation in subjects at risk for atherothrombotic … EM Ohman, DL Bhatt, PG Steg, S Goto, AT Hirsch, CS Liau, JL Mas, ... American heart journal 151 (4), 786. e1-786. e10, 2006 | 367 | 2006 |
| Characterization of the Unique Mechanism Mediating the Shear-dependent Binding of Soluble von Willebrand Factor to Platelets (∗) S Goto, DR Salomon, Y Ikeda, ZM Ruggeri Journal of Biological Chemistry 270 (40), 23352-23361, 1995 | 354 | 1995 |
| Basic principles of platelet biology and clinical implications DJ Angiolillo, M Ueno, S Goto Circulation Journal 74 (4), 597-607, 2010 | 353 | 2010 |
Deepak L. Bhatt, MD, MPH, MBADr. Valentin Fuster Professor of Cardiovascular Medicine, Icahn School of Medicine at Mount Sinai確認したメール アドレス: post.harvard.edu
